Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Harte-Hanks Inc. (HHS) Stock Forecast & Price Prediction United States | NASDAQ | Industrials | Conglomerates
$2.54
+0.03 (1.20%)Did HHS Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Harte-Hanks is one of their latest high-conviction picks.
HHS has shown a year-to-date change of -15.6% and a 1-year change of -41.6%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for HHS. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for HHS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 9, 2017 | Noble Capital Markets | Buy | Upgrade | $N/A | |
| Mar 14, 2016 | BMO Capital | Market Perform | Downgrade | $N/A | |
| Dec 8, 2015 | Singular Research | Buy | Initiates | $N/A | |
| Jul 21, 2015 | BMO Capital | Outperform | Upgrade | $N/A | |
| May 30, 2014 | BMO Capital | Market Perform | Downgrade | $N/A | |
| Oct 21, 2013 | Noble Capital Markets | Hold | Downgrade | $N/A | |
| Oct 4, 2013 | BMO Capital | Outperform | Upgrade | $N/A | |
| Apr 26, 2013 | Noble Capital Markets | Buy | Upgrade | $N/A | |
| Feb 1, 2013 | Noble Capital Markets | Hold | Downgrade | $N/A | |
| Feb 1, 2013 | BMO Capital | Market Perform | Maintains | $N/A | |
| Oct 26, 2012 | Noble Capital Markets | Buy | Upgrade | $N/A | |
| Oct 26, 2012 | BMO Capital | Market Perform | Maintains | $N/A | |
| Jul 18, 2012 | Noble Capital Markets | Hold | Downgrade | $N/A |
The following stocks are similar to Harte-Hanks based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Harte-Hanks Inc. has a market capitalization of $18.85M with a P/E ratio of 2.3x. The company generates $155.27M in trailing twelve-month revenue with a -0.7% profit margin.
Revenue growth is -10.3% quarter-over-quarter, while maintaining an operating margin of -1.6% and return on equity of -5.0%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides multi-channel marketing solutions and services.
The company generates revenue by offering a range of marketing services, including data management, analytics, customer care, and digital marketing. By integrating both traditional and digital channels, it helps businesses enhance customer engagement and loyalty, thereby addressing complex marketing challenges for diverse sectors such as retail, finance, automotive, and healthcare.
Harte-Hanks is recognized for its ability to drive marketing transformation through data-driven insights, making it a valuable partner for companies in a competitive marketplace. Headquartered in the United States, it leverages its extensive experience to adapt and innovate within the marketing services industry.
Industrials
Conglomerates
1,719
Mr. Kirk A. Davis
United States
1993
Harte Hanks, Inc. (NASDAQ:HHS) reported Q1 2026 results, showing revenue pressure but continued operational progress and new business wins while maintaining a strong balance sheet and positive EBITDA.
Harte Hanks' focus on growth despite revenue pressure signals resilience and strategic positioning, potentially attracting investor interest in its long-term value and operational strength.
Harte Hanks, Inc. (NASDAQ:HHS) reported positive FY 2025 EBITDA and highlighted efforts to streamline operations in its Q4 and full year results ending December 31, 2025.
Positive EBITDA signals financial health and operational efficiency, potentially boosting investor confidence and stock performance for Harte Hanks.
Harte Hanks, Inc. reported Q3 2025 revenue of $39.5 million, down from $47.6 million in Q3 2024, citing timing and transitions in legacy contracts. The company announced a new partnership with Samsung.
Harte Hanks' revenue decline signals potential challenges, but the new Samsung partnership suggests future growth opportunities, impacting investor sentiment and stock performance.
Harte Hanks (NASDAQ:HHS) opened a new Customer Care center in Greenville, SC, in partnership with Samsung Electronics, creating over 150 jobs in the area.
Harte Hanks' new Customer Care center with Samsung enhances its service capabilities, potentially boosting revenue and market position, while creating jobs, which can positively impact local economies and investor sentiment.
Harte Hanks (NASDAQ:HHS) reported Q2 2025 results with positive EBITDA, a debt-free balance sheet, and strong cash position, despite facing top-line challenges.
Harte Hanks' positive EBITDA amid revenue challenges and a debt-free balance sheet signals financial stability and operational strength, attracting investor confidence and potential stock appreciation.
Analyst forecasts for Harte-Hanks Inc. (HHS) are not currently available. The stock is trading at $2.54.
According to current analyst ratings, HHS has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.54. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for HHS are not currently available. The stock is trading at $2.54.
The company generates revenue by offering a range of marketing services, including data management, analytics, customer care, and digital marketing. By integrating both traditional and digital channels, it helps businesses enhance customer engagement and loyalty, thereby addressing complex marketing challenges for diverse sectors such as retail, finance, automotive, and healthcare.
Price targets from Wall Street analysts for HHS are not currently available. The stock is trading at $2.54.
Price targets from Wall Street analysts for HHS are not currently available. The stock is trading at $2.54.
The overall analyst consensus for HHS is bullish. Out of 1 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
Stock price projections, including those for Harte-Hanks Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.